Qiyan Zeng

Dr. Qiyan Zeng


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2020 in Aging
Verified
Journal Article
Open access
BWBo Wang
Bo Wang
YZYangyang Zhang
Yangyang Zhang
HZHaitian Zhang
Haitian Zhang
FLFaquan Lin
Faquan Lin
QTQixin Tan
Qixin Tan
QZQiyan Zeng
Qiyan Zeng
Mounting evidence suggests that long noncoding RNAs serve as specific biomarkers and potent modulators of multiple cancers. Long intergenic non-protein coding RNA 324 (LINC00324) is ubiquitously expressed in various tissues, including breast cancer. The biological function of LINC00324 in the development and progression of breast cancer remains unknown. Here, we fully elucidate the relation between LINC00324 expression and breast cancer, and suggest a potential mechanism of action. We found that decreased expression of LINC00324 was dramatically correlated with malignancy of breast cancer, both in breast cancer tissues and in cell lines. Overexpression of LINC00324 in MDA-MB-231 cells resulted in a decrease in cell proliferation, invasion, and migration, while increasing cells apoptosis. On the other hand, loss-of-function experiments indicated that deficiency of LINC00324 promoted malignant phenotypes in breast cancer cells. Mechanically, we found that LINC00324 is mainly distributed in the cytoplasm, fostering the expression of E-cadherin by sponging miR-10b-5p. Taken together, these findings suggest that LINC00324 plays a critical role in breast cancer progression by directly interacting with miR-10b-5p. LINC00324 can thus potentially act as an early diagnostic marker and a novel therapeutic agent for breast cancer.

23 December 2009 in Biotechnology and Applied Biochemistry
Verified
Journal Article
Closed access
PDF file
QZQiyan Zeng
Qiyan Zeng
YHYu Huang
Yu Huang
LZLinjie Zeng
Linjie Zeng
XLXiuwan Lan
Xiuwan Lan
YHYongqi Huang
Yongqi Huang
HZHong Zhang
Hong Zhang

14 June 2023 in Immunity, Inflammation and Disease
Verified
Journal Article
Open access
BXBinbin Xie
Binbin Xie
FLFaquan Lin
Faquan Lin
WBWei Bao
Wei Bao
YZYangyang Zhang
Yangyang Zhang
YLYi Liu
Yi Liu
QZQiyan Zeng
Qiyan Zeng
Background: Altered expressions of genes in immune cells and synovial tissues are involved in the pathology of rheumatoid arthritis (RA). Long noncoding RNAs act as competing endogenous RNAs and can cause immune disorders. The goal of this study was to reveal the association between noncoding RNA linc00324 and RA, and a plausible action mechanism was proposed.Methods: RT‐qPCR was used to evaluate the expression of linc00324 in peripheral blood mononuclear cells isolated from 50 RA patients and 50 healthy controls, and the correlations between linc00324 level and the clinical indicators were analyzed. Flow cytometry was used to characterize CD4+ T cells. The effects of linc00324 on cytokine production and cell proliferation of CD4+ T cells were evaluated by ELISA assay and Western blot. The interaction between linc00324 and miR‐10a‐5p was investigated by RNA immunoprecipitation and dual‐luciferase assays.Results: The linc00324 expression was significantly enhanced in RA patients, and linc00324 expression was positively correlated with rheumatoid factor and CD4+ T cells. Overexpression of linc00324 promoted CD4+ T cells proliferation, and enhanced chemokine MIP‐1α secretion and NF‐κB phosphorylation level, whereas knockout of linc00324 blocked CD4+ T cell proliferation and NF‐κB phosphorylation. Overexpression of miR‐10a‐5p led to the decrease of CD4+ T cells proliferation and NF‐κB phosphorylation, and reversed the effects of linc00324 on cell proliferation and NF‐κB activity.Conclusion: Linc00324 was upregulated in RA and may exaggerate inflammation by targeting miR‐10a‐5p through NF‐κB signaling pathway.

1 September 2012 in Cancer Genetics
Verified
Journal Article
Closed access
QZQiyan Zeng
Qiyan Zeng
YHYu Huang
Yu Huang
LZLinjie Zeng
Linjie Zeng
YHYongqi Huang
Yongqi Huang
DCDanzhao Cai
Danzhao Cai
HZHong Zhang
Hong Zhang

12 April 2018 in Journal of Natural Medicines
Verified
Journal Article
Closed access
PDF file
LZLinjie Zeng
Linjie Zeng
LLLu Li
Lu Li
QZQiyan Zeng
Qiyan Zeng
YDYong Deng
Yong Deng
LYLijun Yin
Lijun Yin
LLLiejun Liao
Liejun Liao

15 May 2014 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
QZQiyan Zeng
Qiyan Zeng
LZLin-Jie Zeng
Lin-Jie Zeng
YHYu Huang
Yu Huang
YHYong-Qi Huang
Yong-Qi Huang
QZQi-Fang Zhu
Qi-Fang Zhu
ZLZhi-Hong Liao
Zhi-Hong Liao
Protein phosphatase 1 (PP1) is a major serine/threonine phosphatase that controls gene expression and cell cycle progression. The active mutant IPP5 (8-60hIPP5(m)), the latest member of the inhibitory molecules for PP1, has been shown to inhibit the growth of human cervix carcinoma cells (HeLa). In order to elucidate the underlying mechanisms, the present study assessed overexpression of 8-60hIPP5(m) in HeLa cells. Flow cytometric and biochemical analyses showed that overexpression of 8-60hIPP5(m) induced G2/M-phase arrest, which was accompanied by the upregulation of cyclin B1 and phosphorylation of G2/M-phase proteins ATM, p53, p21(cip1/waf1) and Cdc2, suggesting that 8-60hIPP5(m) induces G2/M arrest through activation of the ATM/p53/p21(cip1/waf1)/Cdc2/ cyclin B1 pathways. We further showed that overexpression of 8-60hIPP5(m) led to delayed nuclear translocation of cyclin B1. 8-60hIPP5(m) also could translocate to the nucleus in G2/M phase and interact with pp1α and Cdc2 as demonstrated by co-precipitation assay. Taken together, our data demonstrate a novel role for 8-60hIPP5(m) in regulation of cell cycle in HeLa cells, possibly contributing to the development of new therapeutic strategies for cervix carcinoma.